Nora Rabah Rodden

Nora Rabah Rodden possesses a diverse background in strategic planning and operations within the biopharmaceutical sector. Currently serving as the Director of Strategy & Operations at Addition Therapeutics, Nora has previously held the position of Associate Director of Corporate Strategy & Market Planning at Alector. Prior experience includes a role as a Commercial Summer Associate at Genentech and as an Investment Banking Analyst at MTS Health Partners, L.P. This combination of experiences highlights Nora Rabah Rodden's expertise in both corporate strategy and market dynamics in the healthcare industry.